Kunming Wen

Zunyi Medical University

Papers

1

Total Citations

20

H-Index

1

About

Kunming Wen is a leading surgical oncologist whose research focuses on minimally invasive treatments for gastric cancer, particularly the comparative effectiveness of robotic versus laparoscopic gastrectomy. In his landmark 2021 meta-analysis, Wen systematically evaluated propensity-score-matched and randomized controlled trials to compare robotic and conventional laparoscopic approaches for gastric cancer. His work demonstrated that robotic gastrectomy offers comparable oncological outcomes to laparoscopic surgery, with potential advantages in perioperative safety and lymph node dissection. This study, which has garnered over 20 citations, provides crucial evidence guiding surgical decision-making for gastric cancer patients. Wen’s contributions have helped clarify the role of robotic surgery in gastrointestinal oncology, offering surgeons and patients a clearer understanding of its benefits and limitations. His rigorous methodology and focus on high-quality evidence have established him as a key voice in the ongoing debate over the adoption of robotic platforms in cancer surgery. Wen’s research continues to shape best practices in gastric cancer treatment, balancing technological innovation with proven clinical outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Long-Term and Perioperative Outcomes of Robotic Versus Conventional Laparoscopic Gastrectomy for Gastric Cancer: A Systematic Review and Meta-Analysis of PSM and RCT Studies
20 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Zunyi Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago